These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21592681)

  • 1. Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine.
    Zorick T; Sugar CA; Hellemann G; Shoptaw S; London ED
    Drug Alcohol Depend; 2011 Nov; 118(2-3):500-3. PubMed ID: 21592681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence.
    Shoptaw S; Huber A; Peck J; Yang X; Liu J; Jeff Dang ; Roll J; Shapiro B; Rotheram-Fuller E; Ling W
    Drug Alcohol Depend; 2006 Oct; 85(1):12-8. PubMed ID: 16621339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study.
    Wilson KC; Mottram PG; Ashworth L; Abou-Saleh MT
    Br J Psychiatry; 2003 Jun; 182():492-7. PubMed ID: 12777339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
    Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind clinical trial of sertraline treatment for alcohol dependence.
    Pettinati HM; Volpicelli JR; Luck G; Kranzler HR; Rukstalis MR; Cnaan A
    J Clin Psychopharmacol; 2001 Apr; 21(2):143-53. PubMed ID: 11270910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
    Kocsis JH; Schatzberg A; Rush AJ; Klein DN; Howland R; Gniwesch L; Davis SM; Harrison W
    Arch Gen Psychiatry; 2002 Aug; 59(8):723-8. PubMed ID: 12150648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.
    Galloway GP; Buscemi R; Coyle JR; Flower K; Siegrist JD; Fiske LA; Baggott MJ; Li L; Polcin D; Chen CY; Mendelson J
    Clin Pharmacol Ther; 2011 Feb; 89(2):276-82. PubMed ID: 21178989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.
    Roche DJO; Worley MJ; Courtney KE; Bujarski S; London ED; Shoptaw S; Ray LA
    Psychopharmacology (Berl); 2017 Jul; 234(13):1997-2007. PubMed ID: 28357460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.
    Fann JR; Bombardier CH; Temkin N; Esselman P; Warms C; Barber J; Dikmen S
    J Head Trauma Rehabil; 2017; 32(5):332-342. PubMed ID: 28520672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.
    Hellem TL; Sung YH; Shi XF; Pett MA; Latendresse G; Morgan J; Huber RS; Kuykendall D; Lundberg KJ; Renshaw PF
    J Dual Diagn; 2015; 11(3-4):189-202. PubMed ID: 26457568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
    Papakostas GI; Petersen T; Worthington JJ; Roffi PA; Alpert JE; Fava M; Nierenberg AA
    Int Clin Psychopharmacol; 2003 Sep; 18(5):293-6. PubMed ID: 12920390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.